Found 0 matching trials
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation PHASE1 Background:
Blood cancers (such as leukemias or lymphomas) often do not re...
Show More Learn More & Join Trial
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer PHASE2 RATIONALE: Monoclonal antibodies such as daclizumab can locate tumor cells ...
Show More Location
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Learn More & Join Trial
Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines NA For both healthy adults and patients with cardiovascular disease (CVD), aer...
Show More Location
University of Stirling
Learn More & Join Trial
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies PHASE2 This is a single arm, phase II trial of HLA-haploidentical related hematopo...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders NA This study is designed to test the ability to achieve donor hematopoietic e...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Allogeneic Transplant in HIV Patients (BMT CTN 0903) PHASE2 The rationale for this trial is to demonstrate the feasibility and safety o...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer PHASE1 Men with progressive metastatic Castration-Resistant Prostate Cancer post f...
Show More Location
Johns Hopkins Hospital
Learn More & Join Trial
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide EARLY_PHASE1 Background:
CGD causes infections and inflammation. The only cure currentl...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory N/A PET-based consolidation and donor-based therapy after rescue in patients wi...
Show More Location
Istituto di Ematologia e Oncologia Medica, Policlinico S. Orsola
Learn More & Join Trial
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia PHASE2 The purpose of this study is to find out if using a lower dose of chemother...
Show More Location
Dana-Farber Cancer Institute/Harvard Cancer Center, Brigham and Women's Hospital and Massachusetts General Hospital
Learn More & Join Trial